title: Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy.
authors.forename: Andreas
authors.initials: A
authors.lastname: van Baalen
authors.forename: Sarah
authors.initials: S
authors.lastname: von Spiczak
authors.forename: Ulrich
authors.initials: U
authors.lastname: Stephani
authors.forename: Gunther
authors.initials: G
authors.lastname: Fischer
mesh_terms: D000293:Adolescent; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004280:Dobutamine / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007262:Infusions, Intravenous / Q000379:methods; D008297:Male; D020388:Muscular Dystrophy, Duchenne / Q000150:complications* / Q000503:physiopathology; D013997:Time Factors
chemical_list: D002316:Cardiotonic Agents; D004280:Dobutamine